Abstract
•Semi-quantitative Ktrans modeling may influence leaky CMB classification.•Absolute T1 mapping could improve BBB permeability accuracy.•Lesion location may outweigh lesion count for prognostic value.•Peripheral IFN-γ levels require longitudinal mechanistic validation.•Continuous BBB modeling may refine TBI biomarker stratification.